Imperial College London
Portrait Picture

ProfessorBobBrown

Faculty of Medicine, Department of Surgery & Cancer

Senior Research Investigator
 
 
 
//

Contact

 

+44 (0)20 7594 1804b.brown Website

 
 
//

Assistant

 

Ms Sophie Lions +44 (0)20 7594 2792

 
//

Location

 

1 007Institute of Reproductive and Developmental BiologyHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Wilhelm-Benartzi:2016:10.1016/j.critrevonc.2016.12.008,
author = {Wilhelm-Benartzi, CS and Mt-Isa, S and Fiorentino, F and Brown, R and Ashby, D},
doi = {10.1016/j.critrevonc.2016.12.008},
journal = {Critical Reviews in Oncology/Hematology},
pages = {49--61},
title = {Challenges and methodology in the incorporation of biomarkers in cancer clinical trials.},
url = {http://dx.doi.org/10.1016/j.critrevonc.2016.12.008},
volume = {110},
year = {2016}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Biomarkers can be used to establish more homogeneous groups using the genetic makeup of the tumour to inform the selection of treatment for each individual patient. However, proper preclinical work and stringent validation are needed before taking forward biomarkers into confirmatory studies. Despite the challenges, incorporation of biomarkers into clinical trials could better target appropriate patients, and potentially be lifesaving. The authors conducted a systematic review to describe marker-based and adaptive design methodology for their integration in clinical trials, and to further describe the associated practical challenges. Studies published between 1990 to November 2015 were searched on PubMed. Titles, abstracts and full text articles were reviewed to identify relevant studies. Of the 4438 studies examined, 57 studies were included. The authors conclude that the proposed approaches may readily help researchers to design biomarker trials, but novel approaches are still needed.
AU  - Wilhelm-Benartzi,CS
AU  - Mt-Isa,S
AU  - Fiorentino,F
AU  - Brown,R
AU  - Ashby,D
DO  - 10.1016/j.critrevonc.2016.12.008
EP  - 61
PY  - 2016///
SN  - 1040-8428
SP  - 49
TI  - Challenges and methodology in the incorporation of biomarkers in cancer clinical trials.
T2  - Critical Reviews in Oncology/Hematology
UR  - http://dx.doi.org/10.1016/j.critrevonc.2016.12.008
UR  - http://www.ncbi.nlm.nih.gov/pubmed/28109405
UR  - http://hdl.handle.net/10044/1/44684
VL  - 110
ER  -
Download